Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis.
Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications.
Atarax: Can I Order
Vaccines and multiple sclerosis: a systematic review.
Measurement characteristics and clinical utility of the Brief Pain Inventory-Short Form for individuals with multiple sclerosis.
Multiple sclerosis and related disorders: evolving pathophysiologic insights.
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.
Purinergic signalling in the urinary tract in health and disease.
Multiple Sclerosis: Changes in Thalamic Resting-State Functional Connectivity Induced by a Home-based Cognitive Rehabilitation Program.
Measurement and maintenance of reserve in multiple sclerosis.
Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms.
[Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis.
Self-esteem, social participation, and quality of life in patients with multiple sclerosis.
Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.
[Relevance of Magnet Resonance Tomography in the Diagnosis and Assessment of Course of Disease in Patients with Multiple Sclerosis].
Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.
Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States.
CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?
Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.
Strength: A Relevant Link to Functional Performance in the Neurodegenerative Disease of Adrenomyeloneuropathy.
Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
Challenges In Translating The Multiple Sclerosis International Quality of Life (Musiqol) Questionnaire In 57 Languages.
Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany.
Pages
« first
‹ previous
…
704
705
706
707
708
709
710
711
712
…
next ›
last »